These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36542412)

  • 61. EMAS position statement: Testosterone replacement therapy in the aging male‏.
    Dimopoulou C; Ceausu I; Depypere H; Lambrinoudaki I; Mueck A; Pérez-López FR; Rees M; van der Schouw YT; Senturk LM; Simonsini T; Stevenson JC; Stute P; Goulis DG
    Maturitas; 2016 Feb; 84():94-9. PubMed ID: 26614257
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy.
    Salman M; Yassin DJ; Shoukfeh H; Nettleship JE; Yassin A
    Aging Male; 2017 Mar; 20(1):45-48. PubMed ID: 28084147
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Testosterone supplementary therapy for type-2 diabetes mellitus males with hypogonadism: Controversy and analysis].
    Cheng Z; Zhang LY; Chen GM; He W; Cai K; Liao ZH
    Zhonghua Nan Ke Xue; 2017 Aug; 23(8):739-744. PubMed ID: 29726651
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of testosterone replacement therapy on insulin sensitivity and body composition in congenital hypogonadism: A prospective longitudinal follow-up study.
    Reddy KC; Yadav SB
    J Postgrad Med; 2021; 67(2):67-74. PubMed ID: 33942770
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors.
    Hackett G; Cole N; Mulay A; Strange RC; Ramachandran S
    BJU Int; 2019 Mar; 123(3):519-529. PubMed ID: 30216622
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The Role of Testosterone in the Elderly: What Do We Know?
    Barone B; Napolitano L; Abate M; Cirillo L; Reccia P; Passaro F; Turco C; Morra S; Mastrangelo F; Scarpato A; Amicuzi U; Morgera V; Romano L; Calace FP; Pandolfo SD; De Luca L; Aveta A; Sicignano E; Trivellato M; Spena G; D'Alterio C; Fusco GM; Vitale R; Arcaniolo D; Crocetto F
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408895
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial.
    Khripun I; Vorobyev S; Belousov I; Kogan M; Zitzmann M
    Aging Male; 2019 Dec; 22(4):241-249. PubMed ID: 30235049
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study.
    Li H; Mitchell L; Zhang X; Heiselman D; Motsko S
    J Sex Med; 2017 Nov; 14(11):1307-1317. PubMed ID: 29110802
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Controversial aspects of testosterone in the regulation of sexual function in late-onset hypogonadism.
    Maggi M; Filippi S; Vignozzi L; Rastrelli G
    Andrology; 2020 Nov; 8(6):1580-1589. PubMed ID: 32248652
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism.
    Pencina KM; Travison TG; Cunningham GR; Lincoff AM; Nissen SE; Khera M; Miller MG; Flevaris P; Li X; Wannemuehler K; Bhasin S
    J Clin Endocrinol Metab; 2024 Jan; 109(2):569-580. PubMed ID: 37589949
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT
    J Androl; 2009; 30(4):370-6. PubMed ID: 18772486
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Screening for hypogonadism in diabetes 2008/9: results from the Cheshire Primary Care cohort.
    Anderson SG; Heald A; Younger N; Bujawansa S; Narayanan RP; McCulloch A; Jones H
    Prim Care Diabetes; 2012 Jul; 6(2):143-8. PubMed ID: 21982717
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Predictors and clinical consequences of starting androgen therapy in men with low testosterone: results from the SIAMO-NOI registry.
    Rastrelli G; Giovannini L; Calogero AE; Gianfrilli D; Serra E; Pizzocaro A; Giagulli VA; Motta G; Vancieri G; Sperandio A; Andò S; Selice R; Luca G; Cocchiara F; Canale D; Maggi M
    J Endocrinol Invest; 2016 Jun; 39(6):695-708. PubMed ID: 27037688
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Testosterone Increases the Expression and Phosphorylation of AMP Kinase α in Men With Hypogonadism and Type 2 Diabetes.
    Ghanim H; Dhindsa S; Batra M; Green K; Abuaysheh S; Kuhadiya ND; Makdissi A; Chaudhuri A; Sandhu S; Dandona P
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1169-75. PubMed ID: 31858126
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diabetes Mellitus-Associated Functional Hypercortisolism Impairs Sexual Function in Male Late-Onset Hypogonadism.
    Tirabassi G; Corona G; Lamonica GR; Lenzi A; Maggi M; Balercia G
    Horm Metab Res; 2016 Jan; 48(1):48-53. PubMed ID: 25951320
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Patients with testosterone deficiency syndrome and type 2 diabetes.
    Corona G; Maggi M
    Arch Esp Urol; 2013 Sep; 66(7):711-22. PubMed ID: 24047631
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism.
    Naharci MI; Pinar M; Bolu E; Olgun A
    Endocr Pract; 2007 Oct; 13(6):629-35. PubMed ID: 17954419
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity.
    Dandona P; Dhindsa S
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2643-51. PubMed ID: 21896895
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.
    Muraleedharan V; Marsh H; Kapoor D; Channer KS; Jones TH
    Eur J Endocrinol; 2013 Dec; 169(6):725-33. PubMed ID: 23999642
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes.
    Groti K; Žuran I; Antonič B; Foršnarič L; Pfeifer M
    Aging Male; 2018 Sep; 21(3):158-169. PubMed ID: 29708829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.